Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Net sales $ 10,997 $ 3,066,000 $ 741,910 $ 4,888,037
Cost of sales 1,476,822 7,558,082 4,847,097 12,866,095
Gross loss (1,465,825) (4,492,082) (4,105,187) (7,978,058)
Operating Expenses        
Selling, general and administrative 3,363,103 2,808,696 8,766,452 7,309,868
Research and development 1,449,497 5,084,419 5,681,840 14,139,074
Total operating expenses 4,812,600 7,893,115 14,448,292 21,448,942
Interest expense, net 734,542 26,891 1,786,591 84,394
Change in fair value of common stock warrant liability (1,527,414) (1,527,414)
Net loss (5,485,553) (12,412,088) (18,812,656) (29,511,394)
Deemed dividend - September 2017 Warrants 765,179
Net loss attributable to common stockholders $ (5,485,553) $ (12,412,088) $ (19,577,835) $ (29,511,394)
Net loss attributable to common stockholders per share - basic and diluted $ (0.12) $ (0.35) $ (0.42) $ (0.82)
Weighted average number of common shares outstanding 46,192,471 35,930,125 46,192,471 35,930,125